Wednesday, 4 September 2019

AstraZeneca's Tagrisso helps lung cancer patients live longer: study

(This corrects August 9 story to show study points to overall survival and not progression free survival in first paragraph.)


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)